Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia (2016)
Attributed to:
International Severe Acute Respiratory and Emerging Infections Consortium
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3201/eid2209.151164
PubMed Identifier: 27532807
Publication URI: http://europepmc.org/abstract/MED/27532807
Type: Journal Article/Review
Parent Publication: Emerging Infectious Diseases
Issue: 9
ISSN: 1080-6040